BioSpace News Archive

Monteris Medical announced today that the application for two new Category Level I CPT® code(s) for laser interstitial thermal therapy (LITT) of intracranial lesion, with magnetic resonance (MR) imaging guidance has been accepted by the American Medical Association (AMA) CPT® (Current Procedure Terminology) Editorial Panel. This

The Urology Care Foundation, the official Foundation of the American Urological Association, is drawing on the month of November to help break the stigma surrounding bladder health issues and to offer the resources to raise awareness and help start the conversation between a patient and their healthcare provider.

aNew Orders; Production and Employment Growing; Supplier Deliveries Slowing at Faster Rate; Backlog Growing; Raw Materials Inventories Growing; Customers’ Inventories Too Low; Prices Increasing; Exports and Imports Growing

Company’s high-resolution preimplantation genetic testing platform enables discovery of unexpected - and unintended - CRISPR changes to human embryonic DNA.

miR Scientific, LLC, a healthcare company whose purpose is to transform global cancer management, and the Puerto Rico Health Insurance Administration (“ASES”) announced today the signing of a cooperation agreement aimed at evaluating the clinical and economic utility of the miR Sentinel™ PCC4 Assay (miR Sentinel™ Prostate Test) and its potential impact in Puerto Rico.

PARI Pharma GmbH, a company focused on the development, manufacturing and commercialisation of advanced aerosol delivery systems based on eFlow Technology, announces the issue of the CE declaration of conformity for its optimised eFlow Technology LAMIRA Nebuliser System.

SOL Global Investments Corp. (“SOL Global” or the “Company”) (CSE: SOL) (OTCPK: SOLCF) (Frankfurt: 9SB) is pleased to announce its financial results as at and for three and nine-months ended August 31, 2020.

PPD, Inc. (Nasdaq: PPD ), was named the Clinical Research Company of the Year for winning multiple awards at the PharmaTimes Clinical Researcher of the Year competitions. In addition to PPD winning the highest honor at the PharmaTimes International Clinical Researcher of the Year 2020 virtual awards ceremony, individual PPD clinical researchers won gold and bronze in both the Clinical Research Associate (CRA) and

Chiesi USA , Inc. , the U.S. affiliate of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), received U.S. Food and Drug Administration (FDA) approval of Bronchitol® (mannitol) inhalation powder. Bronchitol is the first and only inhaled dry powder indicated as add-on maintenance therapy to improve pulmonary function in cystic fibrosis (CF) patients 18 years of age and older. It provides a compact, por

Hoth Therapeutics expects key proof-of-concept data in Q4 2020 / Q1 2021 for its COVID-19 products it is currently developing